• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁过载的危害。

The hazards of iron loading.

机构信息

Department of Biology and Program in Medical Sciences, Indiana University, Bloomington, IN 47405, USA.

出版信息

Metallomics. 2010 Nov;2(11):732-40. doi: 10.1039/c0mt00023j. Epub 2010 Sep 24.

DOI:10.1039/c0mt00023j
PMID:21072364
Abstract

Excessive or misplaced tissue iron now is recognized to pose a substantial health risk for an extensive array of endocrinological, gastrointestinal, infectious, neoplasmic, neurodegenerative, obstetric, ophthalmic, orthopedic, pulmonary and vascular diseases. Ingested, injected, inhaled and decompartmentalized iron contributes not only to disease, but also to aging and mortality. Iron is dangerous by catalyzing free radical formation and by serving as an essential nutrient for microbial and neoplasmic cell invaders. Our body cells exhibit wide variation in sensitivity to iron toxicity. Efficacy of our iron withholding defense system is modulated by numerous environmental, behavioral and genetic factors. A notable variety of methods for prevention and therapy of iron toxicity are now becoming available.

摘要

目前,人们认识到过多或错位的组织铁对广泛的内分泌、胃肠道、传染病、肿瘤、神经退行性、产科、眼科、骨科、肺部和血管疾病构成了重大健康风险。摄入、注射、吸入和隔室化的铁不仅导致疾病,还导致衰老和死亡。铁通过催化自由基形成和作为微生物和肿瘤细胞入侵的必需营养素而变得危险。我们的体细胞对铁毒性的敏感性差异很大。我们的铁扣留防御系统的功效受到许多环境、行为和遗传因素的调节。现在有许多种预防和治疗铁毒性的方法。

相似文献

1
The hazards of iron loading.铁过载的危害。
Metallomics. 2010 Nov;2(11):732-40. doi: 10.1039/c0mt00023j. Epub 2010 Sep 24.
2
Therapeutic potential of iron chelators in diseases associated with iron mismanagement.铁螯合剂在与铁管理不当相关疾病中的治疗潜力。
J Pharm Pharmacol. 2006 May;58(5):575-84. doi: 10.1211/jpp.58.5.0001.
3
Is addition of iron to processed foods safe for iron replete consumers?加工食品中添加铁对于铁营养充足的消费者安全吗?
Med Hypotheses. 2009 Dec;73(6):948-9. doi: 10.1016/j.mehy.2009.06.030. Epub 2009 Jul 23.
4
Iron out-of-balance: a risk factor for acute and chronic diseases.铁失衡:急慢性疾病的一个风险因素。
Hemoglobin. 2008;32(1-2):117-22. doi: 10.1080/03630260701680805.
5
Iron overload and toxicity: the hidden risk of multiple blood transfusions.铁过载和毒性:多次输血的隐藏风险。
Vox Sang. 2009 Oct;97(3):185-97. doi: 10.1111/j.1423-0410.2009.01207.x. Epub 2009 Aug 3.
6
[The efficacy of phlebotomy with a low iron diet in the management of pulmonary iron overload].低铁饮食放血疗法治疗肺铁过载的疗效
Rinsho Ketsueki. 2003 May;44(5):323-7.
7
Chronic iron overload and toxicity: clinical chemistry perspective.慢性铁过载与毒性:临床化学视角
Clin Lab Sci. 2001 Summer;14(3):209-19; quiz 222.
8
Iron loading and disease surveillance.铁负荷与疾病监测。
Emerg Infect Dis. 1999 May-Jun;5(3):346-52. doi: 10.3201/eid0503.990305.
9
Lowering body iron stores in the prevention of type 2 diabetes.降低体内铁储存以预防2型糖尿病。
Intern Med J. 2006 Oct;36(10):685-6. doi: 10.1111/j.1445-5994.2006.01186.x.
10
Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases.正常铁储存患者(包括地中海贫血、神经退行性、肾脏和传染病患者)中铁螯合治疗的安全性问题。
Expert Opin Drug Saf. 2010 Mar;9(2):201-6. doi: 10.1517/14740330903535845.

引用本文的文献

1
Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury.铜、铁、镉、砷,宇宙中全部生成:阐明其对人类健康包括临床肝损伤的环境影响风险。
Int J Mol Sci. 2024 Jun 17;25(12):6662. doi: 10.3390/ijms25126662.
2
PICK1 modulates glycolysis and angiogenesis of hypoxic endothelial cells by regulating iron homeostasis.PICK1 通过调节铁稳态调节低氧内皮细胞的糖酵解和血管生成。
Mol Cell Biochem. 2024 May;479(5):1297-1312. doi: 10.1007/s11010-023-04795-z. Epub 2023 Jun 27.
3
Nutritional Aspects of Iron in Health and Disease.
营养与健康和疾病中的铁元素
Nutrients. 2023 May 24;15(11):2441. doi: 10.3390/nu15112441.
4
Potential intervention target of atherosclerosis: Ferroptosis (Review).动脉粥样硬化的潜在干预靶点:铁死亡(综述)。
Mol Med Rep. 2022 Nov;26(5). doi: 10.3892/mmr.2022.12859. Epub 2022 Sep 23.
5
Taurine Ameliorates Iron Overload-Induced Hepatocyte Injury via the Bcl-2/VDAC1-Mediated Mitochondrial Apoptosis Pathway.牛磺酸通过 Bcl-2/VDAC1 介导的线粒体凋亡途径减轻铁过载诱导的肝细胞损伤。
Oxid Med Cell Longev. 2022 Jul 16;2022:4135752. doi: 10.1155/2022/4135752. eCollection 2022.
6
Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1, Wnt/-Catenin, and p38MAPK/ERK Pathways.去铁胺通过抑制ROS/HIF-1、Wnt/β-连环蛋白和p38MAPK/ERK信号通路来抑制急性淋巴细胞白血病进展。
J Oncol. 2022 Feb 21;2022:8281267. doi: 10.1155/2022/8281267. eCollection 2022.
7
Enhanced Fe binding through cooperativity of 3-hydroxypyridin-4-one groups within a linear co-polymer: wrapping effect leading to superior antimicrobial activity.通过线性共聚物中3-羟基吡啶-4-酮基团的协同作用增强铁结合:包裹效应导致卓越的抗菌活性。
Biometals. 2020 Dec;33(6):339-351. doi: 10.1007/s10534-020-00253-1. Epub 2020 Oct 19.
8
Physicochemical characterization of ferric pyrophosphate citrate.柠檬酸铁焦磷酸酯的理化特性分析。
Biometals. 2018 Dec;31(6):1091-1099. doi: 10.1007/s10534-018-0151-1. Epub 2018 Oct 15.
9
DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity.DIBI,一种具有增强抗菌活性的3-羟基吡啶-4-酮螯合铁结合聚合物。
Medchemcomm. 2018 Jun 18;9(7):1206-1212. doi: 10.1039/c8md00192h. eCollection 2018 Jul 1.
10
High-Dose Deferoxamine Treatment Disrupts Intracellular Iron Homeostasis, Reduces Growth, and Induces Apoptosis in Metastatic and Nonmetastatic Breast Cancer Cell Lines.高剂量去铁胺治疗破坏细胞内铁稳态,降低转移性和非转移性乳腺癌细胞系的生长并诱导其凋亡。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818764470. doi: 10.1177/1533033818764470.